Tachycardia in Hypertension: A Saga of Progress Despite Prejudice, Confusion, and Inertia

Progress in Cardiovascular Diseases

Volumn 52, Issue 1, 2009, Pages 26-30

  Julius, Stevo ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cardiovascular; Hyperkinetic; Hypertension; Sympathetic; Tachycardia

Indexed keywords

BRETYLIUM; GANGLION BLOCKING AGENT; GUANETHIDINE; VERATRUM ALKALOID;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; EMOTION; GASTROINTESTINAL SYMPTOM; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPERTENSION; MEDICAL SOCIETY; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; PRACTICE GUIDELINE; RISK FACTOR; TACHYCARDIA; VALIDITY; VASCULAR RESISTANCE;

BIAS (EPIDEMIOLOGY); BLOOD PRESSURE; CARDIAC OUTPUT; HEMODYNAMICS; HUMANS; HYPERTENSION; RISK FACTORS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA;

EID: 67650242083     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.06.002     Document Type: Article

References (37)

1. Smirk F.H. Results of methonium treatment of hypertensive patients. Br Med J 1 4864 (1954) 717-723
2. Goldring W., and Chasis H. Antihypertensive drug therapy: An appraisal. In: Ingelfinger F.J., Relman A.S., and Finland M. (Eds). Controversy in internal medicine (1966), W. B. Saunders Company 83-91 Reprinted
3. Doyle A.E. Sir Horace Smirk: Pioneer in drug treatment of hypertension. Hypertension 17 (1991) 247-250
4. Parati G., Pomidossi G., Albini F., et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5 (1987) 93-98
5. Levy R.L., White P.D., Strod W.D., et al. Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 129 (1945) 585-588
6. Dyer A., Persky V., Stamler J., et al. Heart rate as a prognostic factor for coronary heart disease and mortality findings in three Chicago Epidemiological Studies. Am J Epidemiol 112 (1980) 736-749
7. Julius S., Ellis C.N., Pascual A.V., et al. Home blood pressure determination: Value in borderline ("labile") hypertension. JAMA 229 (1974) 663-666
8. Widimsky J., Fejfarova M.H., and Fejfar Z. Changes of cardiac output in hypertensive disease. Cardiologia 31 (1957) 381-389
9. Eich R.H., Peters R.J., Cuddy R.P., et al. The hemodynamics in labile hypertension. Am Heart J 63 (1962) 188-195
10. Bello C.T., Sevy R.W., and Harakal C. Varying hemodynamic patterns in essential hypertension. Am J Med Sci 250 (1965) 24-35
11. Frohlich E.D., Kozul V.J., Tarazi R.C., et al. Physiological comparison of labile and essential hypertension. Circ Res 26 Suppl 1 (1970) 55-69
12. Messerli F.H., De Carvalho J.G.R., Christie B., et al. Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation 58 (1978) 441-448
13. Julius S., and Conway J. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 38 (1968) 282-288
14. Lund-Johansen P. Hemodynamics in early essential hypertension. Acta Med Scand 482 Suppl (1967) 1-105
15. Sannerstedt R. Hemodynamic response to exercise in patients with arterial hypertension. Acta Med Scand 458 Suppl 458 (1966) 1-83
16. Finkielman S., Worcel M., and Agrest A. Hemodynamic patterns in essential hypertension. Circulation 31 (1965) 356-368
17. Safar M.E., Weiss Y.A., Levenson J.A., et al. Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol 31 (1973) 315-319
18. Kuramoto K., Murata K., Yazaki Y., et al. Hemodynamics in juvenile hypertension with special reference to action of propranolol. Jpn Circ J 32 (1968) 981-987
19. Julius S., Pascual A.V., and London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 44 (1971) 413-418
20. Lund-Johansen P., and Omvik P. Hemodynamic patterns of untreated hypertensive disease. In: Laragh J.H., and Brenner B.M. (Eds). Hypertension: Pathophysiology, diagnosis, and management. 2nd ed. (1995), Raven Press, New York, NY 323-342
21. Julius S., Krause L., Schork N.J., et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertension 9 (1991) 77-84
22. Palatini P., and Julius S. Heart rate and the cardiovascular risk. J Hypertens 15 (1997) 1-15
23. Palatini P., Benetos A., and Julius S. Impact of increased heart rate on clinical outcomes in hypertension. Drugs 66 (2006) 133-144
24. Fox K., Borer J.S., Camm A.J., et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50 (2007) 823-830
25. Julius S., Pascual A.V., Abbrecht P., et al. Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med 140 (1972) 982-985
26. Cohn J.N. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin Sci 30 (1966) 267-278
27. Julius S., Pascual A., Reilly K., et al. Abnormalities of plasma volume in borderline hypertension. Arch Intern Med 127 (1971) 116-119
28. Smith S., Julius S., Jamerson K., et al. Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh. Michigan. J Hypertens 12 (1994) 455-462
29. Julius S., Randall O.S., Esler M.D., et al. Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res 36-37 Suppl I (1975) I-199-I-207
30. Kjeldsen S.E., Zweifler A.J., Petrin J., et al. Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased β-adrenoreceptor responsiveness. Blood Pressure 3 (1994) 164-171
31. Wiggers C.J. Studies on cardiodynamic actions of drugs: mechanism of cardiac stimulation by epinephrine. J Pharmacol Exp Ther 30 (1927) 233-250
32. Valentini M., Julius S., Palatini P., et al. Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 22 (2004) 1999-2006
33. Julius S., Jamerson K., Mejia A., et al. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 264 (1990) 354-358
34. Julius S., Gudbrandsson T., Jamerson K., et al. Hypothesis. The hemodynamic link between insulin resistance and hypertension. J Hypertension 9 (1991) 983-986
35. Jamerson K.A., Julius S., Gudbrandsson T., et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21 (1993) 618-623
36. Beere P.A., Glagov S., and Zarins C.K. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 226 (1984) 180-182
37. Lown B., and Verrier R. Neural activity and ventricular fibrillation. N Engl J Med 294 (1976) 1165-1170